Lessons Learned in Neuroscience Drug Development: How Biomarker-based, Evidence-driven Decisions Enable Successful Outcomes Webinar Replay
Watch this webinar replay to learn how biomarker-supported endpoints and evidence-driven strategies can strengthen neuroscience clinical trials and support earlier development decisions.
Key takeaways from this webinar:
- Understand the value of identifying clinically meaningful, biomarker-supported evidence of target engagement early in neuroscience clinical development
- Review practical examples of endpoints, biomarkers and outcome assessments that can detect treatment effects with greater sensitivity
- Identify opportunities to optimize study design and sample size while improving statistical power through more informed endpoint strategies
- Validate a drug’s mechanism of action and therapeutic potential earlier in development
- Make more confident go/no-go decisions prior to investing in larger and more expensive late-phase trials
- Mitigate development risk by leveraging high-quality neurobehavioral, cognitive and digital measures